GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Total Stockholders Equity

3D Global Biotech (ROCO:6808) Total Stockholders Equity : NT$904.7 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Total Stockholders Equity?

3D Global Biotech's Total Stockholders Equity for the quarter that ended in Dec. 2024 was NT$904.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. 3D Global Biotech's Book Value per Share for the quarter that ended in Dec. 2024 was NT$11.62. The ratio of a company's debt over equity can be used to measure how leveraged this company is. 3D Global Biotech's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.09.

3D Global Biotech Total Stockholders Equity Historical Data

The historical data trend for 3D Global Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Total Stockholders Equity Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial 448.82 389.71 340.60 293.47 904.69

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 340.60 312.53 293.47 457.04 904.69

3D Global Biotech  (ROCO:6808) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

3D Global Biotech's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(904.69-0)/77.840
=11.62

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

3D Global Biotech's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(10.999 + 73.765) / 904.69
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Global Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Total Stockholders Equity
Comparable Companies
ROCO:3176 ROCO:06891 ROCO:1777 ROCO:6945 TPE:6838 TPE:6794 ROCO:8279 ROCO:4178 ROCO:6733 ROCO:6634 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
Website
https://www.3dglobalbiotech.com.tw
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.

3D Global Biotech Headlines

No Headlines